This prospective study assessed the prevalence of pulmonary hypertension (PHT) related to chronic myeloproliferative neoplasms (CMPNs) and evaluated the impact of PHT on survival during long-term follow-up. In a large group of BCR-ABL1-negative CMPN patients, there was a low prevalence of PHT. The impact of PHT on survival was negligible
Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare disease which is often caused by re...
Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare disease which is often caused by rec...
Pulmonary hypertension (PH) associated to chronic lung disease (CLD) is relatively frequent in end-s...
This prospective study assessed the prevalence of pulmonary hypertension (PHT) related to chronic my...
This prospective study assessed the prevalence of pulmonary hypertension (PHT) related to chronic my...
Myeloproliferative neoplasm (MPN) has been associated with pulmonary hypertension (PH) on the basis ...
hypertension in patients with chronic myeloproliferative disorders Y. Adir * and M. Humbert# ABSTRAC...
Pulmonary hypertension (PH) is a major complication of several haematological disorders. Chronic mye...
BACKGROUND: Pulmonary hypertension (PH) can complicate the course of myeloproliferative neoplasms (M...
Background: Pulmonary hypertension (PH) can complicate the course of myeloproliferative neoplasms (M...
The impact of primary arterial hypertension (HTN) in myeloproliferative neoplasms (MPNs) remains unc...
BackgroundIncreased bone marrow hemangioblast numbers, alterations in erythroid/myeloid lineages, in...
BackgroundMultiple myeloma is often complicated by pulmonary hypertension through a variety of mecha...
Background: Strong evidence indicates that venous thromboembolism is a presenting symptom of cancer....
Background: Chronic myeloproliferative disorders (CMPD) seem to be associated with an increased risk...
Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare disease which is often caused by re...
Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare disease which is often caused by rec...
Pulmonary hypertension (PH) associated to chronic lung disease (CLD) is relatively frequent in end-s...
This prospective study assessed the prevalence of pulmonary hypertension (PHT) related to chronic my...
This prospective study assessed the prevalence of pulmonary hypertension (PHT) related to chronic my...
Myeloproliferative neoplasm (MPN) has been associated with pulmonary hypertension (PH) on the basis ...
hypertension in patients with chronic myeloproliferative disorders Y. Adir * and M. Humbert# ABSTRAC...
Pulmonary hypertension (PH) is a major complication of several haematological disorders. Chronic mye...
BACKGROUND: Pulmonary hypertension (PH) can complicate the course of myeloproliferative neoplasms (M...
Background: Pulmonary hypertension (PH) can complicate the course of myeloproliferative neoplasms (M...
The impact of primary arterial hypertension (HTN) in myeloproliferative neoplasms (MPNs) remains unc...
BackgroundIncreased bone marrow hemangioblast numbers, alterations in erythroid/myeloid lineages, in...
BackgroundMultiple myeloma is often complicated by pulmonary hypertension through a variety of mecha...
Background: Strong evidence indicates that venous thromboembolism is a presenting symptom of cancer....
Background: Chronic myeloproliferative disorders (CMPD) seem to be associated with an increased risk...
Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare disease which is often caused by re...
Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare disease which is often caused by rec...
Pulmonary hypertension (PH) associated to chronic lung disease (CLD) is relatively frequent in end-s...